VIVOZON PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 082800 for the last quarter is 20.87 B KRW, and it's 5.10% higher compared to the previous quarter. The net income of Q2 24 is -522.45 M KRW.